A new international structuring entity, co-directed by Arnaud Droit (Université Laval), Pierre Nioche (Université Paris Cité), and with scientific direction from Jérôme Estaquier (Inserm), has been created to accelerate research on infectious diseases. This initiative, recognized by Inserm as a "Joint Lab", aims to unite French and Canadian expertise.
In a context of globalization, urbanization, and climate change, intensified interactions foster the emergence of new pathogens. The LIA aims to develop a common expertise based on omics sciences and artificial intelligence to better understand and combat these threats.
"By combining advances in artificial intelligence with integrative biology approaches and multi-omics data analysis, we aim to deepen our understanding of the complex interactions between pathogens and their hosts," jointly state Arnaud Droit and Pierre Nioche. This interdisciplinary approach will accelerate biomarker identification and improve diagnostic and therapeutic strategies.
This scientific alliance will promote student and scientific mobility between Quebec and France, as well as the sharing of cutting-edge infrastructure, data, and knowledge. Eugénie Brouillet, Vice-Rector for Research at Université Laval, emphasizes that this partnership strengthens the collective capacity to combat emerging infectious diseases.
Maximilien Cazayous, Dean of the Faculty of Sciences at Université Paris Cité, and Professor Didier Samuel, CEO of Inserm, express their pride in this project, which will train a new generation of talents and become an international benchmark. Nicolas Douay, scientific cooperation attaché, highlights the richness of collaborations between France and Quebec.




